We are live on
!
Find out more
Corcept Therapeutics
CORT
CORT
59 hedge funds and large institutions have $161M invested in Corcept Therapeutics in 2014 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 24 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,034% more call options, than puts
Call options by funds: $2.64M | Put options by funds: $233K
300% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 6
275% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 4
49% more capital invested
Capital invested by funds: $108M → $161M (+$52.6M)
20% more funds holding
Funds holding: 49 → 59 (+10)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
59
Holders Change
+10
Holders Change %
+20.41%
% of All Funds
1.7%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
24
Reduced
6
Closed
4
Calls
$2.64M
Puts
$233K
Net Calls
+$2.41M
Net Calls Change
+$2.36M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$4.36M |
| 2 |
ISL
Ingalls & Snyder LLC
New York
|
+$3.49M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$1.99M |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$1.1M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$779K |
Top Sellers
| 1 |
First Eagle Investment Management
New York
|
-$3.19M |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$197K |
| 3 |
TG
TCW Group
Los Angeles,
California
|
-$125K |
| 4 |
D.E. Shaw & Co
New York
|
-$46K |
| 5 |
Citigroup
New York
|
-$27.7K |
